Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Operating Income (2017 - 2026)

Inspire Medical Systems' Operating Income history spans 10 years, with the latest figure at -$1.1 million for Q1 2026.

  • On a quarterly basis, Operating Income rose 24.71% to -$1.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $51.3 million, a 3.02% increase, with the full-year FY2025 number at $51.0 million, up 41.21% from a year prior.
  • Operating Income hit -$1.1 million in Q1 2026 for Inspire Medical Systems, down from $46.1 million in the prior quarter.
  • Over the last five years, Operating Income for INSP hit a ceiling of $46.1 million in Q4 2025 and a floor of -$19.5 million in Q1 2023.
  • Historically, Operating Income has averaged -$114352.9 across 5 years, with a median of -$1.5 million in 2025.
  • Biggest five-year swings in Operating Income: soared 2875.22% in 2023 and later crashed 165.03% in 2025.
  • Tracing INSP's Operating Income over 5 years: stood at -$335000.0 in 2022, then soared by 2875.22% to $9.3 million in 2023, then skyrocketed by 242.95% to $31.9 million in 2024, then soared by 44.62% to $46.1 million in 2025, then plummeted by 102.42% to -$1.1 million in 2026.
  • Business Quant data shows Operating Income for INSP at -$1.1 million in Q1 2026, $46.1 million in Q4 2025, and $9.6 million in Q3 2025.